Global Heparin Market 2015-2019 is a new market research publication announced by Reportstack. Heparin is an anticoagulant or blood thinner produced by basophils and mast cells. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to function and dissolve clots. A porcine intestine or bovine lungs extract of heparin is used pharmaceutically in conditions such as DVT, pulmonary embolism, acute coronary syndrome, and atrial fibrillation to prevent clots. It is also used during surgeries to prevent clot formation.
The analysts forecast that the global heparin market to grow at a CAGR of -4.80% over the period 2014-2019.
To access full report with TOC, please visit Global Heparin Market 2015-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the global heparin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of generic and branded therapeutic products, including
• Unfractionated heparin (UFH)
• Low molecular weight heparin (LMWH)
• Ultra low molecular weight heparin (ULMWH)
The report, Global Heparin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes the discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Aspen
• Leo Pharma
• Pfizer
• Sanofi-Aventis
Other Prominent Vendors
This report covers the present scenario and the growth prospects of the global heparin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of generic and branded therapeutic products, including
• Unfractionated heparin (UFH)
• Low molecular weight heparin (LMWH)
• Ultra low molecular weight heparin (ULMWH)
The report, Global Heparin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes the discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Aspen
• Leo Pharma
• Pfizer
• Sanofi-Aventis
Other Prominent Vendors
• Archimedes Pharma
• Celgene
• Dr. Reddy's
• Eisai
• Laboratorios Rovi Pharmaceuticals
• Lee's Pharmaceutical
• Menarini Group
• Mylan
• Sagent Pharmaceuticals
• Fresenius Kabi
• GlaxoSmithKline
• Hospira
• Sigma Tau
• UCB
Market Driver
• Increasing Prevalence of Diseases
• For a full, detailed list, view our report
Market Challenge
• Generic Drug Use
• For a full, detailed list, view our report
Market Trend
• Expected Exploitation of New Therapeutic Use
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
• Increasing Prevalence of Diseases
• For a full, detailed list, view our report
Market Challenge
• Generic Drug Use
• For a full, detailed list, view our report
Market Trend
• Expected Exploitation of New Therapeutic Use
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Companies Mentioned
Aspen, Leo Pharma, Pfizer, Sanofi-Aventis, Alchemia, Archimedes Pharma, Celgene, Dr. Reddy's, Eisai, Laboratorios Rovi Pharmaceuticals, Lee's Pharmaceutical, Menarini Group, Mylan, Sagent Pharmaceuticals, Fresenius Kabi, GlaxoSmithKline, Hospira, Sigma Tau, UCB
Contact:
Debora White
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
###
Manager - Marketing
debora@reportstack.com
Ph: +1-888-789-6604
Reportstack Market Research
###
No comments:
Post a Comment